Longduoduo Co Ltd (LDDD)
Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services. The company's comprehensive suite of offerings includes health screenings, diverse treatment options, and specialized healthcare products, all aimed at reducing the likelihood of severe conditions such as myocardial infarction (heart attacks), cerebral infarction (strokes), hemiplegia (paralysis), and other cardiovascular and cerebrovascular diseases. These services are delivered through an extensive network of external collaborators, including independent healthcare providers, product vendors, and sales representatives. Additionally, Longduoduo features a range of advanced therapeutic interventions. These encompass meridian-regulating and consciousness-restoring techniques, a double blood purification process, immunological ozonated autohemotherapy, platelet-rich plasma therapy, relaxation techniques, vegetative nerve regulation, and microwave therapy. Established in 2020, the firm's primary operational base is located in Hohhot, China.
Sector: Services-Health Services
Industry: Medical - Diagnostics & Research
Longduoduo Company Limited
OTC:LDDDHealthcare · Medical - Diagnostics & Research
Mkt Cap-
Float9.71M
O/S-
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$1.82M
Net Income-$579K
Total Assets$2.06M
Free Cash Flow-$194K
Debt & Equity
Debt 7%
Equity 93%
Total Debt$49K
Total Equity$704K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:10Reverse splitSep 27, 202310 shares → 1
Balance Sheet Details
Assets$2.06M
Liabilities$1.31M
Accounts Receivable$57K
Accounts Payable$403K
Inventory$0
PP&E (Net)$279K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Revenue | $1.82M | $4.26M | $7.39M | $3.82M | $3.24M | $414K |
| YoY Growth | -57.2% | -42.3% | 93.5% | 17.9% | 682.4% | - |
| Cost of Revenue | $17K | $91K | $173K | $592K | $1.01M | $94K |
| Gross Profit | $1.81M | $4.17M | $7.22M | $3.23M | $2.23M | $320K |
| Gross Margin | 99.1% | 97.9% | 97.7% | 84.5% | 69.0% | 77.2% |
| Research and Development | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $2.44M | $3.62M | $5.19M | $3.2M | $9.79M | $698K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $2.44M | $3.62M | $5.19M | $3.2M | $9.79M | $698K |
| Operating Income (EBIT) | -$633K | $553K | $2.03M | $29K | -$7.56M | -$378K |
| Operating Margin | -34.7% | 13.0% | 27.4% | 0.8% | -233.3% | -91.4% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $57K | $162K | -$140K | $2K | -$7K | $210 |
| Income Before Tax (EBT) | -$576K | $715K | $1.89M | $31K | -$7.56M | -$378K |
| Income Tax Expense | $66K | $222K | $523K | $10K | $2K | $0 |
| Net Income | -$579K | $460K | $1.26M | -$39K | -$7.52M | -$329K |
| Net Income Margin | -31.8% | 10.8% | 17.0% | -1.0% | -232.2% | -79.4% |
| Supplementary Data | ||||||
| EPS | -0.02 | 0.02 | 0.04 | -0.00 | -0.25 | -0.00 |
| Diluted EPS | -0.02 | 0.02 | 0.04 | -0.00 | -0.25 | -0.00 |
| Weighted Average OS | 30.02M | 30.01M | 30.01M | 30.00M | 30.00M | 300.00M |
| EBITDA | -$523K | $852K | $1.99M | $99K | -$7.5M | -$376K |
| EBITDA Margin | -28.7% | 20.0% | 26.9% | 2.6% | -231.5% | -90.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $1.59M | $1.64M | $1.4M | $1.14M | $357K | $273K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.59M | $1.64M | $1.4M | $1.14M | $357K | $273K |
| Accounts Receivable | $57K | $37K | $131K | $107K | $31K | $74K |
| Inventory | $0 | $0 | $0 | $820 | $3K | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $1.78M | $1.81M | $1.66M | $1.31M | $424K | $355K |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $279K | $313K | $404K | $166K | $186K | $158K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $4K | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $279K | $313K | $404K | $170K | $186K | $158K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.06M | $2.13M | $2.06M | $1.48M | $611K | $514K |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $403K | $400K | $359K | $1.04M | $41K | $180K |
| Short-Term Debt | $24K | $0 | $0 | $0 | $143K | $51K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $790K | $335K | $713K | $588K | $789K | $0 |
| Other Current Liabilities | $65K | $26K | $87K | $128K | $332K | $628K |
| Total Current Liabilities | $1.28M | $830K | $1.26M | $2.05M | $1.63M | $859K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $25K | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $25K | $0 | $18K | $7K | $3K | $40K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.31M | $830K | $1.28M | $2.05M | $1.63M | $899K |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $30K | $30K | $30K | $30K | $30K | $164K |
| Retained Earnings | -$6.75M | -$6.17M | -$6.63M | -$7.89M | -$7.85M | -$329K |
| Comprehensive Income & Other | $175K | $77K | $55K | $66K | $25K | -$6K |
| Other Stockholders' Equity | $7.42M | $7.32M | $7.3M | $7.31M | $6.89M | -$170K |
| Total Equity | $704K | $1.18M | $703K | -$542K | -$929K | -$334K |
| Minority Interest | $52K | $111K | $78K | -$29K | -$94K | -$51K |
| Total Liabilities and Equity | $2.01M | $2.02M | $1.99M | $1.51M | $704K | $565K |
| Supplementary Data | ||||||
| Total Debt | $49K | $19K | $36K | $13K | $181K | $91K |
| Net Debt | -$1.54M | -$1.62M | -$1.37M | -$1.12M | -$175K | -$182K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Operating Activities | ||||||
| Net Income | -$579K | $492K | $1.36M | $21K | -$7.56M | -$329K |
| Depreciation & Amortization | $111K | $137K | $102K | $68K | $66K | $2K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $385K | $6.74M | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | -$17K | $115K | -$30K | -$135K | -$12K | -$73K |
| Inventory | $0 | $0 | $830 | $2K | -$3K | $0 |
| Accounts Payable | -$18K | $36K | -$689K | $1.05M | -$138K | $180K |
| Other Working Capital | $362K | -$548K | -$219K | -$468K | $886K | $606K |
| Total Working Capital Change | $327K | -$397K | -$938K | $449K | $733K | $713K |
| Other Non-Cash Items | -$22K | $44K | $55K | $43K | $54K | -$36K |
| Net Cash from Operating | -$163K | $277K | $582K | $965K | $29K | $350K |
| Investing Activities | ||||||
| Capital Expenditures | -$31K | -$59K | -$305K | -$120K | -$112K | -$70K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$6K | $0 | $0 |
| Net Cash from Investing | -$31K | -$59K | -$305K | -$126K | -$112K | -$70K |
| Financing Activities | ||||||
| Debt Repaid | - | - | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $31K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $0 | $0 | $0 | -$143K | $180K | $0 |
| Forex Effect | $140K | $21K | -$9K | $84K | -$13K | -$8K |
| Net Change in Cash | -$54K | $239K | $267K | $780K | $84K | $273K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$163K | $277K | $582K | $965K | $29K | $350K |
| Capital Expenditure | -$31K | -$59K | -$305K | -$126K | -$112K | -$70K |
| Free Cash Flow | -$194K | $218K | $277K | $839K | -$83K | $281K |
| Cash at Beginning | $1.64M | $1.4M | $1.14M | $357K | $273K | $0 |
| Cash at End | $1.59M | $1.64M | $1.4M | $1.14M | $357K | $273K |